MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
545.74%
Quick Ratio
330.01%
Debt to Asset Ratio
18.12%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Inventory
    • Accounts receivable
    • Others
Liabilities Breakdown
    • Capital paid in excess of par va...
    • Accumulated (deficit)
    • Total current liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
13,748,301
6,913,013
9,123,308
9,306,438
Accounts receivable
4,035,360
4,011,632
3,459,864
4,155,599
Inventory
12,121,796
13,168,430
13,472,025
14,063,706
Deposits
281,480
71,740
-
-
Prepaid expenses
478,490
618,361
798,384
441,489
Total current assets
30,665,427
24,783,176
26,853,581
27,967,232
Property & equipment
477,047
516,349
557,370
598,087
Intangible assets
1,841,970
1,917,812
1,889,370
2,009,337
Deferred tax asset
-
-
0
92,234
Right-of-use-asset
648,457
713,038
778,846
820,489
Total long-term assets
2,967,474
3,147,199
3,225,586
3,520,147
Total assets
33,632,901
27,930,375
30,079,167
31,487,379
Accounts payable & accrued expenses
4,852,488
5,104,868
5,664,212
6,137,465
Earnout payable
295,797
295,797
295,797
295,797
Income tax payable
268,276
268,276
268,276
0
Right-of-use-liability
202,518
209,226
215,637
218,053
Total current liabilities
5,619,079
5,878,167
6,443,922
6,651,315
Right-of-use-liability
475,820
535,614
596,785
636,708
Total long-term liabilities
475,820
535,614
596,785
636,708
Total liabilities
6,094,899
6,413,781
7,040,707
7,288,023
Preferred stock series b 0.10 par value per share 1,000,000 shares authorized 130,000 shares issued and outstanding
13,000
13,000
13,000
13,000
Common stock 0.001 par value per share 3,000,000,000 shares authorized 2,388,516 shares issued and outstanding at june 30, 2026 and 490,595 shares issued and outstanding at december 31, 2025
2,389
4,905
4,905
4,555
Capital paid in excess of par value
106,004,591
98,100,990
98,100,990
97,376,841
Accumulated comprehensive income
-658,935
-343,306
-65,309
-320,841
Accumulated (deficit)
-77,823,043
-76,258,995
-75,015,126
-72,874,199
Total shareholders' equity
27,538,002
21,516,594
23,038,460
24,199,356
Total liabilities and shareholders' equity
33,632,901
27,930,375
30,079,167
31,487,379
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$13,748,301 (33.41%↑ Y/Y)Inventory$12,121,796 (-6.89%↓ Y/Y)Accounts receivable$4,035,360 (12.48%↑ Y/Y)Prepaid expenses$478,490 (-49.07%↓ Y/Y)Deposits$281,480 Intangible assets$1,841,970 (-26.05%↓ Y/Y)Right-of-use-asset$648,457 (-27.37%↓ Y/Y)Property & equipment$477,047 (-25.27%↓ Y/Y)Total current assets$30,665,427 (10.11%↑ Y/Y)Total long-termassets$2,967,474 (-27.87%↓ Y/Y)Total assets$33,632,901 (5.22%↑ Y/Y)Total liabilities andshareholders' equity$33,632,901 (5.22%↑ Y/Y)Total shareholders'equity$27,538,002 (7.22%↑ Y/Y)Total liabilities$6,094,899 (-2.95%↓ Y/Y)Accumulated (deficit)-$77,823,043 (-8.10%↓ Y/Y)Accumulated comprehensiveincome-$658,935 (-334.67%↓ Y/Y)Capital paid in excess ofpar value$106,004,591 (8.86%↑ Y/Y)Total currentliabilities$5,619,079 (0.81%↑ Y/Y)Total long-termliabilities$475,820 (-32.65%↓ Y/Y)Preferred stock series b0.10 par value per...$13,000 (0.00%↑ Y/Y)Common stock 0.001 parvalue per share...$2,389 (-47.55%↓ Y/Y)Accounts payable &accrued expenses$4,852,488 (1.15%↑ Y/Y)Earnout payable$295,797 (0.00%↑ Y/Y)Income tax payable$268,276 (3.92%↑ Y/Y)Right-of-use-liability$202,518 (-8.98%↓ Y/Y)Right-of-use-liability$475,820 (-32.65%↓ Y/Y)

Sunshine Biopharma Inc. (SBFM)

Sunshine Biopharma Inc. (SBFM)